28 August 2026quiverquant.com

Teva to Bid for BioXcel BXCL501 Film in Court-Supervised Sale

SigSignificance2.26SenSentiment+2.45EnvEnvironment0.00SocSocial+0.63GovGovernance+0.61

SigSignificance3.84SenSentiment-4.87EnvEnvironment0.00SocSocial-0.07GovGovernance-2.10

BXCL501, a dexmedetomidine sublingual film, is under FDA review for potential at-home treatment of agitation linked to schizophrenia or bipolar I/II in adults. Teva has agreed to act as the stalking horse bidder in a court-supervised auction under U.S. Bankruptcy Code Section 363 to buy related assets, including IGALMI®. Completion depends on bankruptcy court approval, possible higher bids, and closing conditions.

Coverage (3)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro